Skip to site menu Skip to page content

Daily Newsletter

18 October 2023

Daily Newsletter

18 October 2023

Children’s Hospital of Wisconsin deploys CareView virtual care tech

It claims to be the first standalone paediatric facility to implement Virtual Nursing system and Virtual Sitting deployment.

October 18 2023

US-based virtual care solutions provider CareView Communications has partnered with paediatric healthcare institution Children's Hospital of Wisconsin.

This collaboration introduces virtual care solutions to the hospital, making it the first standalone paediatric facility to implement a comprehensive Virtual Nursing system as well as Virtual Sitting deployment.

The agreement involves installing 103 CareView cameras, including 92 portable cameras, six fixed cameras, and five mobile carts.

CareView Communications chief clinical officer Cathy Story said: “Children’s Hospital of Wisconsin’s decision to embrace our Virtual Nursing and Virtual Sitting solutions is a testament to their commitment to leveraging advanced technology to deliver the highest standard of care to their young patients.

“We are excited to partner with such a prestigious institution to further enhance patient safety and clinical workflows.”

The paediatric Behavioral Health unit will also benefit from this technology, ensuring a safer environment.

CareView claims to have supported more than 200 hospitals across the nation in deploying virtual care strategies.

Recently, it partnered with Pexip, a secure video technology platform, to enhance its virtual nursing capabilities.

This collaboration aims to provide secure and efficient communication among patients, medical professionals, and support networks, advancing virtual healthcare.

The integration enables two-way video calls, improving patient care coordination and outcomes.

Most recently, CareView showcased its inpatient virtual care platform at the opening of Baptist Health Care's Behavioral Health Unit in Pensacola, Florida.

CareView's technology employs AI and machine learning to predict inpatient falls, providing real-time insights for healthcare providers, and reducing injury-related costs.

AI will become a key driver of medical device innovation

With only a few approved drugs currently available to treat DN by means other than regulation of blood pressure, innovator products that can treat by targeting other factors such as treatment of dyslipidemia, hypertension, or angiotensin inhibition, among others, is a key area of R&D in the DN space and is likely to pave the way for novel therapies in the near future. However, the treatment landscape is expected to remain unchanged due to limited availability of products in the late-stage pipeline currently.

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close